Swiss National Bank Annexon, Inc. Transaction History

Swiss National Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$2.11 - $4.06 $114,995 - $221,269	-54,500 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$2.73 - $11.94 $10,647 - $46,566	3,900 Added 7.71%	54,500 $149,000
Q4 2021 Feb 08, 2022	BUY	$11.49 - $22.0 $195,330 - $374,000	17,000 Added 50.6%	50,600 $581,000
Q2 2021 Aug 06, 2021	BUY	$17.81 - $27.48 $60,553 - $93,432	3,400 Added 11.26%	33,600 $756,000
Q4 2020 Feb 05, 2021	BUY	$20.81 - $30.55 $628,462 - $922,610	30,200 New	30,200 $756,000

156

101M

3.73M

1.3M

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $335M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.